|
|
|
|
|
|
|
|
|
|
|
|
|
|
FTC
Investigation of Microsoft Corporation ("Microsoft 1") |
|
|
Rick Warren-Boulton and Ken
Baseman worked for Novell Corporation in the original FTC
Investigation of Microsoft's OEM licensing practices, especially the "per-processor" license.
When the FTC declined to act, DOJ started its own investigation and
sued Microsoft. MiCRA's work
for Novell resulted in a frequently cited journal article: Warren-Boulton, Baseman,
and Woroch, "Microsoft Plays Hardball: Use of Nonlinear Pricing
and Technical Incompatibility to Exclude Rivals in the Market for
Operating Software," Antitrust Bulletin 40-2 (Summer
1995), pp.265-315. |
|
|
|
|
|
Hewlett-Packard
merger with COMPAQ, Inc. |
|
|
Steve Silberman and Rick
Warren-Boulton were retained by Hewlett-Packard to evaluate
the competitive impact of the proposed merger and present a White
Paper detailing their findings to the DOJ. |
|
|
|
|
|
Power
MOSFET Technologies, LLC v. Siemens, AG, et al. |
|
|
Rick Warren-Boulton and Alan
Rockwood analyzed patent infringement damage claims for a
plaintiff holding patents on the design of a new generation of metal
oxide semiconductor field effect transistors used in power control
applications, and Rick Warren-Boulton testified at trial. |
|
|
|
|
|
Thomas & Betts
v. IBM |
|
|
Lloyd Oliver provided
written and deposition testimony analyzing damages due the plaintiff
as a result of an alleged breach of contract by IBM in failing to make
Thomas & Betts its exclusive manufacturer of computer connectors.
The case was settled on terms favorable to the plaintiff before trial. |
|
|
|
|
|
United
States v. Microsoft Corporation and State of New York ex rel.
v. Microsoft Corporation |
|
|
Rick Warren-Boulton testified
on behalf of the government and plaintiff states that Microsoft had
monopolized the market for PC operating systems and implemented policies
designed to entrench its monopoly position by illegally weakening rivals
such as Netscape that were current for imminent competitive threats. |
|
|
|
|
|
United
States v. Nippon Sanso K. K., et al. |
|
|
Bruce Snapp's testimony
on behalf of defendants concerning market definition and the competitive
effects of defendants' proposed acquisition of Semi-Gas Systems helped
defeat DOJ's request for a preliminary injunction. |
|
|
|
|
|
ZC
Sterling Insurance Agency, Inc. et al. v. Nationsdata.com, Inc.,
et al. |
|
|
Bruce Snapp testified
at trial on behalf of plaintiffs concerning future economic damages
that could result from the defendants' alleged theft of proprietary
information for a software product to manage mortgage escrow accounts. |
|
|
|
|
|
|
|
|
Abraham v. Intermountain Health Care et al. |
|
|
David Eisenstadt presented
testimony using game theory to show that Intermountain had unilateral incentives not to
enter into a contract with the plaintiff class of optometrists. Dr. Eisenstadt also
presented statistical evidence that was inconsistent with plaintiffs’ attempted
monopolization claim and their contention that fees paid to the defendant ophthalmologists
had increased. The case was recently dismissed on summary judgment. |
|
|
|
|
|
|
Bellavia
v. Hackensack, et al. |
|
|
David Eisenstadt testified
that plaintiff's alleged exclusion through staff privilege restrictions
would not harm competition. The Court found for Hackensack. |
|
|
|
|
|
FTC
Retrospective Investigation of Vista Health Merger |
|
|
David Eisenstadt represented
Vista Health in a retrospective hospital merger investigation conducted
by the FTC. His analysis was instrumental in the Commission's decision
to close the investigation. |
|
|
|
|
|
Highmark
et al. v. UPMC Health System |
|
|
David Eisenstadt testified
that UPMC's proposed acquisition of Children's Hospital would be anticompetitive.
UPMC entered into a consent decree with the State of Pennsylvania as
a pre-condition for the acquisition. |
|
|
|
|
|
Holmes
Regional Medical Center v. Agency for Health Care Administration
and Wuesthoff Memorial Hospital |
|
|
David Eisenstadt testified
that Wuesthoff's proposed new hospital was procompetitive. The Agency
for Health Care Administration approved Wuesthoff's Certificate of Need
Application. |
|
|
|
|
|
Holmes Regional Medical Center v. State of Florida and Wuesthoff Memorial Hospital |
|
|
David Eisenstadt successfully
testified that the applicant’s CON, if approved, would reduce competition by impeding
Wuesthoff’s ability to expand its satellite hospital in Melbourne, Florida. |
|
|
|
|
|
Howerton
v. Grace Hospital |
|
|
David Eisenstadt testified
that Grace's alleged exclusion of Howerton through denial of staff privileges
would not harm competition. The Court found for Grace Hospital. |
|
|
|
|
|
Kochert v.
Greater Lafayette Health Services |
|
|
A case recently dismissed on summary judgment,
David Eisenstadt testified that competition was not adversely affected by the defendant’s
decision to not renew plaintiff’s anesthesiology contract. |
|
|
|
|
|
M&M
Medical Supplies & Services v. Pleasant Valley Hospital |
|
|
Steve Silberman testified
at trial that there was no economic evidence that Pleasant Valley Hospital
had steered patients to a related medical supplies company. The jury
found the hospital innocent of any wrong doing. |
|
|
|
|
|
Orlando
Regional Healthcare System, Inc. and Orlando Regional South Seminole,
Inc. v. Columbia/HCA Healthcare Corporation |
|
|
Jon Joyce provided
an expert witness affidavit and expert testimony at a preliminary injunction
hearing and at trial on market definition and competitive effects from
a proposed acquisition. |
|
|
|
|
|
Rome Ambulatory Surgery Center v. Rome Memorial Hospital |
|
|
David Eisenstadt testified that Rome Memorial Hospital’s exclusive contracts with several major third-party payers constituted predatory and exclusionary conduct and were the cause of plaintiff’s exit from the ambulatory surgery market. |
|
|
|
|
|
United
States v. Carilion Health System |
|
|
David Eisenstadt testified
at trial that the proposed merger would not raise hospital prices. His
testimony helped persuade the Court and jury to rule in favor of Carilion. |
|
|
|
|
|
Ventana
Medical Systems, Inc. petitioner to the US Department of Energy |
|
|
Under certain federal contract
terms, patents resulting from those research grants must be licensed
in a manner that will promote competition. Rick Warren-Boulton and Alan
Rockwood provided an expert witness report and Warren-Boulton
also testified at the Department of Energy hearing for the petitioner
on the competitive effects of certain actions and sub-license demands
by Vysis, the patent holder's exclusive licensee. |
|
|
|
|
|
Wichita
Clinic, P.A. v. Columbia/HCA Healthcare Corporation |
|
|
Jon Joyce provided
expert witness reports and deposition testimony for the Plaintiff. |
|
|
|
|
|
|
|
|
EEC
Investigation of Contract between Arco Chemical and Repsol |
|
|
Lloyd Oliver provided
testimony before the EEC concerning market shares, definition and significance
of merchant markets and competitive effects in an EEC investigation
of allegedly restrictive provisions of a contract between Arco Chemical
and Repsol for producing propylene oxide in Europe. |
|
|
|
|
|
In
Re: Vitamins Antitrust Litigation |
|
|
Bruce Snapp provided
economic analysis and litigation support for the four niacin defendants
and assisted the testifying economist in the preparation of his expert
report and testimony.
Rick Warren-Boulton submitted a report supporting
defendants' motions to strike the report of an economics expert
hired by the plaintiffs because it did not meet the standards
required under Daubert. |
|
|
|
|
|
Pool
Water Products, et al. v. Olin Corporation, et al. |
|
|
Bruce Snapp submitted
an expert report and declarations and testified at deposition on behalf
of defendants concerning Plaintiffs' allegation that Olin had attempted
monopolize the West Coast swimming pool chemicals distribution market.
The case was eventually dismissed by the judge, whose decision was upheld
by the 9th Circuit. |
|
|
|
|
|
US
and EC Investigations Lyondell Chemical joint venture with Bayer
AG and Bayer's acquisition of Lyondell's worldwide polyether polyols
business. |
|
|
Lloyd Oliver worked
for Lyondell Chemical in helping to secure US and EC approval for a
multibillion dollar joint venture by two propylene oxide producers to
coordinate existing operations and establish new propylene oxide manufacturing
facilities in Europe. He also consulted on Bayer's concomitant acquisition
of Lyondell's worldwide polyether polyols business and helped to analyze
the effects of technology sharing agreements. |
|
|
|
|
|
Cases by Industry Group
1 |
2 |
3 |
|
|
|
|
|
|
|